140 related articles for article (PubMed ID: 7739301)
1. Harnessing the profit motive.
Lancet; 1995 May; 345(8959):1189-90. PubMed ID: 7739301
[No Abstract] [Full Text] [Related]
2. US senator seeks information about medical faculty links to drug industry.
Tanne JH
BMJ; 2009 Jul; 339():b2725. PubMed ID: 19581320
[No Abstract] [Full Text] [Related]
3. Medical professionalism--focusing on the real issues.
Ruane TJ
N Engl J Med; 2000 Sep; 343(10):739-40. PubMed ID: 10979775
[No Abstract] [Full Text] [Related]
4. Look, no strings: publishing industry-funded research.
CMAJ; 2001 Sep; 165(6):733, 735. PubMed ID: 11584556
[No Abstract] [Full Text] [Related]
5. Medical-research ethics under the microscope: schools try to plot the fine line between commercial links and conflicts of interest.
Mangan KS
Chron High Educ; 2003 Jul; 49(46):A22-4. PubMed ID: 15287130
[No Abstract] [Full Text] [Related]
6. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.
Tereskerz PM
Account Res; 2003; 10(3):137-58. PubMed ID: 14979317
[No Abstract] [Full Text] [Related]
7. Few US medical schools and medical centres are disclosing industry ties.
Tanne JH
BMJ; 2010 Feb; 340():c1075. PubMed ID: 20179129
[No Abstract] [Full Text] [Related]
8. A patent to kill? Comments on Resnik.
Justo L
Dev World Bioeth; 2002 May; 2(1):82-7. PubMed ID: 12872772
[No Abstract] [Full Text] [Related]
9. The destruction of medicine by market forces: teaching acquiescence or resistance and change?
Wolfe SM
Acad Med; 2002 Jan; 77(1):5-7. PubMed ID: 11788316
[No Abstract] [Full Text] [Related]
10. Is academic medicine for sale?
Angell M
N Engl J Med; 2000 May; 342(20):1516-8. PubMed ID: 10816191
[No Abstract] [Full Text] [Related]
11. Uneasy alliance--clinical investigators and the pharmaceutical industry.
Bodenheimer T
N Engl J Med; 2000 May; 342(20):1539-44. PubMed ID: 10816196
[No Abstract] [Full Text] [Related]
12. Global health. Public-private partnerships proliferate.
Cohen J
Science; 2006 Jan; 311(5758):167. PubMed ID: 16410497
[No Abstract] [Full Text] [Related]
13. Medical schools found to vary in their drug-testing standards.
Dean C
N Y Times Web; 2005 May; ():A24. PubMed ID: 15981393
[No Abstract] [Full Text] [Related]
14. [Biomedical research: private interests and public interests].
Martin J
Sante Publique; 2001 Mar; 13(1):89-93. PubMed ID: 11525046
[No Abstract] [Full Text] [Related]
15. Ethical relationships between drug companies and the medical profession.
Rosner F
Chest; 1992 Jul; 102(1):266-9. PubMed ID: 1623765
[No Abstract] [Full Text] [Related]
16. Lunch with Lilly: who pays?
Strong C
Am J Bioeth; 2003; 3(3):62-3. PubMed ID: 14594499
[No Abstract] [Full Text] [Related]
17. The Glaxo Award: is the American Public Health Association moving toward corporate governance?
David R
Int J Health Serv; 2002; 32(1):205-7. PubMed ID: 11913858
[No Abstract] [Full Text] [Related]
18. Stanford to ban drug makers' gifts to doctors, even pens.
Pollack A
N Y Times Web; 2006 Sep; ():C2. PubMed ID: 16972375
[No Abstract] [Full Text] [Related]
19. Academia and industry: increasingly uneasy bedfellows.
Weatherall D
Lancet; 2000 May; 355(9215):1574. PubMed ID: 10821359
[No Abstract] [Full Text] [Related]
20. Outlook: finding improved medicines: the role of academic-industrial collaboration.
Chin-Dusting J; Mizrahi J; Jennings G; Fitzgerald D
Nat Rev Drug Discov; 2005 Nov; 4(11):891-7. PubMed ID: 16247439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
